Butterfly Network (BFLY) Share-based Compensation (2020 - 2026)
Butterfly Network (BFLY) reported Share-based Compensation of $5.5 million for Q1 2026, up 99.71% on a YoY basis from $2.8 million in Q1 2025, and down 73.18% sequentially from $20.7 million in Q4 2025.
Butterfly Network (BFLY) Share-based Compensation (2020 - 2026) Analysis & Trends
Butterfly Network (BFLY) has 7 years of Share-based Compensation data on file, last reported at $5.5 million in Q1 2026.
- For the quarter ending Q1 2026, Share-based Compensation rose 99.71% year-over-year to $5.5 million; the trailing twelve-month figure through Mar 2026 stood at $36.9 million (up 8.25% YoY), and the FY2025 full-year result was $23.4 million, up 11.43% from the prior year.
- Share-based Compensation declined to $5.5 million in Q1 2026, from $20.7 million in the prior quarter.
- In the past five years, Share-based Compensation ranged from a high of $21.0 million in Q4 2024 to a low of -$20.9 million in Q4 2023.
- A 5-year average of $7.0 million and a median of $5.9 million in 2025 frame the typical range for Share-based Compensation.
- Across the five-year window, Share-based Compensation tumbled 238.54% in 2023 and surged 200.52% in 2024, its largest moves.
- Tracing BFLY's Share-based Compensation over 5 years: stood at $15.1 million in 2022, then plunged by 238.54% to -$20.9 million in 2023, then surged by 200.52% to $21.0 million in 2024, then slipped by 1.77% to $20.7 million in 2025, then sank by 73.18% to $5.5 million in 2026.
- Business Quant data shows BFLY's Share-based Compensation at $5.5 million in Q1 2026, $20.7 million in Q4 2025, and $4.8 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Share-based Compensation (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.32 Bn | 175.02 Bn | 6.27 Bn | 317.00 Mn |
| 2 | Stryker | 128.75 Bn | 125.88 Bn | 3.81 Bn | 139.00 Mn |
| 3 | Medtronic | 107.83 Bn | 98.61 Bn | 6.41 Bn | 95.00 Mn |
| 4 | Boston Scientific | 67.61 Bn | 66.15 Bn | 3.61 Bn | 83.00 Mn |
| 5 | Edwards Lifesciences | 48.13 Bn | 44.45 Bn | 1.29 Bn | 45.40 Mn |
| 6 | Dexcom | 28.26 Bn | 27.14 Bn | 750.30 Mn | 35.80 Mn |
| 7 | GE HealthCare Technologies | 27.78 Bn | 25.50 Bn | 1.98 Bn | 35.00 Mn |
| 8 | Smith & Nephew | 26.99 Bn | 26.41 Bn | - | - |
| 9 | Koninklijke Philips | 23.92 Bn | 20.80 Bn | 2.07 Bn | 35.12 Mn |
| 10 | Butterfly Network | 1.79 Bn | 1.65 Bn | 18.29 Mn | 5.54 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 5.54 Mn |
| Mar 31, 2026 | 5.54 Mn |
| Dec 31, 2025 | 20.66 Mn |
| Dec 31, 2025 | 20.66 Mn |
| Sep 30, 2025 | 4.83 Mn |
| Sep 30, 2025 | 4.83 Mn |
| Jun 30, 2025 | 5.86 Mn |
| Jun 30, 2025 | 5.86 Mn |
| Mar 31, 2025 | 2.78 Mn |
| Mar 31, 2025 | 2.78 Mn |
| Dec 31, 2024 | 21.03 Mn |
| Dec 31, 2024 | 21.03 Mn |
| Sep 30, 2024 | 4.41 Mn |
| Sep 30, 2024 | 4.41 Mn |
| Jun 30, 2024 | 5.86 Mn |
| Jun 30, 2024 | 5.86 Mn |
| Mar 31, 2024 | 5.52 Mn |
| Mar 31, 2024 | 5.52 Mn |
| Dec 31, 2023 | -20.92 Mn |
| Dec 31, 2023 | -20.92 Mn |